Seeking sweet relief for diabetes

From

View current issue Submit your manuscript

An Erratum to this article was published on 01 February 2003

Diabetes is a modern-day epidemic in the making, but drug developers are still undecided over the best strategy for its treatment.

This is a preview of subscription content, log in via an institution to check access.

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data taken from US Centers for Disease Control web site, http://www.cdc.gov/diabetes.
American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care 21, 296–309 (1998).
Knowler, W.C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).
Article CAS Google Scholar
Barroso, I. et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883 (1999).
Article CAS Google Scholar
Fletcher, L. Oral insulin deal for Nobex. Nat. Biotechnol. 20, 645 (2002).
Steppan, C.M. et al. The hormone resistin links obesity to diabetes. Nature 409, 307–312 (2002).
Article Google Scholar
Sesti, G. Searching for type 2 diabetes genes: prospects in pharmacotherapy. Pharmacogenomics J. 2, 25–29 (2002).
Article CAS Google Scholar
Lumelsky, N. et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389–1394 (2001).
Article CAS Google Scholar

Authors

Alan Dove
View author publications
You can also search for this author in PubMed Google Scholar

Dove, A. Seeking sweet relief for diabetes. Nat Biotechnol 20, 977–981 (2002). https://doi.org/10.1038/nbt1002-977

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.